{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:45:48Z","timestamp":1786992348422,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,17]],"date-time":"2021-10-17T00:00:00Z","timestamp":1634428800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["109-2314-B-002-244-MY3 \uff3d"],"award-info":[{"award-number":["109-2314-B-002-244-MY3 \uff3d"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.jfma.2021.10.010","type":"journal-article","created":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T09:07:43Z","timestamp":1637053663000},"page":"1442-1449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Long-term outcomes of percutaneous left atrial appendage closure for the prevention of stroke in patients with atrial fibrillation: Asia-Pacific experience"],"prefix":"10.1016","volume":"121","author":[{"given":"Fu-Chun","family":"Chiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pang-Shuo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jien-Jiun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juey-Jen","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Ti","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2021.10.010_bib1","first-page":"794","article-title":"Left atrial appendage closure with AMPLATZER cardiac plug for stroke prevention in atrial fibrillation: initial Asia-Pacific experience","volume":"79","author":"Lam","year":"2012","journal-title":"Cathet Cardiovasc Interv"},{"key":"10.1016\/j.jfma.2021.10.010_bib2","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1161\/STROKEAHA.116.015071","article-title":"Stroke as the initial manifestation of atrial fibrillation: the Framingham Heart study","volume":"48","author":"Lubitz","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.jfma.2021.10.010_bib3","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.jfma.2016.10.005","article-title":"2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation","volume":"115","author":"Chiang","year":"2016","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jfma.2021.10.010_bib4","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.amjcard.2017.07.051","article-title":"Comparison of the CHA2DS2-VASc, CHADS2, HAS-BLED, ORBIT, and ATRIA risk scores in predicting non-vitamin K antagonist oral anticoagulants-associated bleeding in patients with atrial fibrillation","volume":"120","author":"Yao","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jfma.2021.10.010_bib5","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.amjmed.2006.07.034","article-title":"Death and disability from warfarin-associated intracranial and extracranial hemorrhages","volume":"120","author":"Fang","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.jfma.2021.10.010_bib6","first-page":"806","article-title":"Left atrial appendage exclusion: state-of-the-art","volume":"75","author":"Cruz-Gonzalez","year":"2010","journal-title":"Cathet Cardiovasc Interv"},{"key":"10.1016\/j.jfma.2021.10.010_bib7","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial","volume":"374","author":"Holmes","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jfma.2021.10.010_bib8","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1001\/jama.2014.15192","article-title":"Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial","volume":"312","author":"Reddy","year":"2014","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.jfma.2021.10.010_bib9","first-page":"700","article-title":"Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience","volume":"77","author":"Park","year":"2011","journal-title":"Cathet Cardiovasc Interv"},{"key":"10.1016\/j.jfma.2021.10.010_bib10","first-page":"283","article-title":"Amplatzer left atrial appendage occlusion: single center 10-year experience","volume":"82","author":"Nietlispach","year":"2013","journal-title":"Cathet Cardiovasc Interv"},{"key":"10.1016\/j.jfma.2021.10.010_bib11","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.4244\/EIJY15M01_06","article-title":"Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug","volume":"11","author":"Tzikas","year":"2016","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jfma.2021.10.010_bib12","doi-asserted-by":"crossref","first-page":"867","DOI":"10.4244\/EIJ-D-17-00493","article-title":"Left atrial appendage occlusion with the AMPLATZER Amulet device: periprocedural and early clinical\/echocardiographic data from a global prospective observational study","volume":"13","author":"Landmesser","year":"2017","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jfma.2021.10.010_bib13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijcard.2017.07.052","article-title":"Left atrial appendage closure using AMPLATZER devices: a large, multicenter, Italian registry","volume":"248","author":"Berti","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jfma.2021.10.010_bib14","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1365-2125.2011.04097.x","article-title":"The pharmacogenetics of the response to warfarin in Chinese","volume":"73","author":"Lam","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jfma.2021.10.010_bib15","article-title":"Risk of bleeding and stroke with oral anticoagulation and antiplatelet therapy in patients with atrial fibrillation in Taiwan: a nationwide cohort study","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jfma.2021.10.010_bib16","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1161\/STROKEAHA.119.025536","article-title":"Effectiveness and safety of contemporary oral anticoagulants among Asians with nonvalvular atrial fibrillation","volume":"50","author":"Lee","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.jfma.2021.10.010_bib17","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jacc.2007.01.098","article-title":"Racial\/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation","volume":"50","author":"Shen","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jfma.2021.10.010_bib18","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1161\/STROKEAHA.113.000990","article-title":"Dabigatran versus warfarin: effects on ischemic and hemorrhagic strokes and bleeding in Asians and non-Asians with atrial fibrillation","volume":"44","author":"Hori","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.jfma.2021.10.010_bib19","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1161\/STROKEAHA.113.002968","article-title":"Rivaroxaban for stroke prevention in East Asian patients from the ROCKET AF trial","volume":"45","author":"Wong","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.jfma.2021.10.010_bib20","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ahj.2014.06.005","article-title":"Efficacy and safety of apixaban compared with warfarin for stroke prevention in patients with atrial fibrillation from East Asia: a subanalysis of the apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trial","volume":"168","author":"Goto","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.jfma.2021.10.010_bib21","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1253\/circj.CJ-15-1082","article-title":"Edoxaban vs. Warfarin in East Asian patients with atrial fibrillation- an ENGAGE AF-TIMI 48 subanalysis","volume":"80","author":"Yamashita","year":"2016","journal-title":"Circ J"},{"key":"10.1016\/j.jfma.2021.10.010_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial","volume":"64","author":"Holmes","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jfma.2021.10.010_bib23","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.4244\/EIJV11I13A292","article-title":"Left atrial appendage occlusion with the AMPLATZER Amulet device: an expert consensus step-by-step approach","volume":"11","author":"Tzikas","year":"2016","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jfma.2021.10.010_bib24","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.ahj.2006.02.005","article-title":"The PROTECT AF (WATCHMAN left atrial appendage system for embolic PROTECTion in patients with atrial fibrillation) trial","volume":"151","author":"Fountain","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.jfma.2021.10.010_bib25","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jacc.2011.11.028","volume":"59","author":"Viles-Gonzalez","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jfma.2021.10.010_bib26","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","article-title":"5-Year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials","volume":"70","author":"Reddy","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jfma.2021.10.010_bib27","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.118.006841","article-title":"Evaluating real-world clinical outcomes in atrial fibrillation patients receiving the WATCHMAN left atrial appendage closure Technology","volume":"12","author":"Boersma","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jfma.2021.10.010_bib28","first-page":"100358","article-title":"Left atrial appendage closure with WATCHMAN in Asian patients: 2 year outcomes from the WASP registry","volume":"23","author":"Phillips","year":"2019","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1016\/j.jfma.2021.10.010_bib29","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1253\/circj.CJ-15-1134","article-title":"Left atrial appendage occlusion in non-valvular atrial fibrillation in a Korean multi-center registry","volume":"80","author":"Kim","year":"2016","journal-title":"Circ J"},{"key":"10.1016\/j.jfma.2021.10.010_bib30","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.amjcard.2018.02.045","article-title":"Feasibility of left atrial appendage occlusion for left atrial appendage thrombus in patients with persistent atrial fibrillation","volume":"121","author":"Lee","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jfma.2021.10.010_bib31","first-page":"314","article-title":"Experience of left atrial appendage occlusion with the WATCHMAN device in Chinese patients","volume":"21","author":"Zhai","year":"2019","journal-title":"Anatol J Cardiol"},{"key":"10.1016\/j.jfma.2021.10.010_bib32","doi-asserted-by":"crossref","first-page":"877","DOI":"10.4244\/EIJ-D-17-00042","article-title":"Safety and efficacy of early anticoagulation drug regimens after WATCHMAN left atrial appendage closure: three-month data from the EWOLUTION prospective, multicentre, monitored international WATCHMAN LAA closure registry","volume":"13","author":"Bergmann","year":"2017","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jfma.2021.10.010_bib33","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.117.005997","article-title":"Device thrombosis after percutaneous left atrial appendage occlusion is related to patient and procedural characteristics but not to duration of postimplantation dual antiplatelet therapy","volume":"11","author":"Pracon","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jfma.2021.10.010_bib34","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.jacc.2018.01.076","article-title":"Device-related thrombosis after percutaneous left atrial appendage occlusion for atrial fibrillation","volume":"71","author":"Fauchier","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jfma.2021.10.010_bib35","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.jacep.2018.09.007","article-title":"Incidence and clinical impact of device-related thrombus following percutaneous left atrial appendage occlusion: a meta-analysis","volume":"4","author":"Alkhouli","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.jfma.2021.10.010_bib36","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jacc.2014.03.057","article-title":"Early safety and efficacy of percutaneous left atrial appendage suture ligation: results from the U.S. transcatheter LAA ligation consortium","volume":"64","author":"Price","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jfma.2021.10.010_bib37","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.jtcvs.2016.06.009","article-title":"A randomized, prospective pilot comparison of 3 atrial appendage elimination techniques: internal ligation, stapled excision, and surgical excision","volume":"152","author":"Lee","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jfma.2021.10.010_bib38","first-page":"728","article-title":"Long-term transesophageal echocardiography follow-up after percutaneous left atrial appendage closure","volume":"175","author":"Staubach","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jfma.2021.10.010_bib39","doi-asserted-by":"crossref","first-page":"42","DOI":"10.15420\/icr.2018.21.3","article-title":"Device-related thrombus after left atrial appendage closure","volume":"14","author":"Garot","year":"2019","journal-title":"Intervent Cardiol"},{"key":"10.1016\/j.jfma.2021.10.010_bib40","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1177\/0218492314548231","article-title":"Experience of left atrial appendage closure performed under conscious sedation","volume":"23","author":"Chan","year":"2015","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"10.1016\/j.jfma.2021.10.010_bib41","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003695","article-title":"Left atrial appendage closure under intracardiac echocardiographic guidance: feasibility and comparison with transesophageal echocardiography","volume":"5","author":"Matsuo","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jfma.2021.10.010_bib42","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1093\/europace\/eux254","article-title":"Left atrial appendage occluder implantation in Europe: indications and anticoagulation post-implantation. Results of the European Heart Rhythm Association Survey","volume":"19","author":"Tilz","year":"2017","journal-title":"Europace"},{"key":"10.1016\/j.jfma.2021.10.010_bib43","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.hrthm.2018.12.013","article-title":"Left atrial appendage closure with the Watchman device using intracardiac vs transesophageal echocardiography: procedural and cost considerations","volume":"16","author":"Hemam","year":"2019","journal-title":"Heart Rhythm"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664621004824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664621004824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:48:56Z","timestamp":1760539736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664621004824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0929664621004824"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2021.10.010","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term outcomes of percutaneous left atrial appendage closure for the prevention of stroke in patients with atrial fibrillation: Asia-Pacific experience","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2021.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}